MOSCOW (Reuters) – Chile has registered the Russian Sputnik V COVID-19 vaccine for use, Russia’s Direct Investment Fund said on Wednesday.
Chile has become the 69th country to authorise the vaccine, according to the fund, which promotes it abroad.
Moscow’s Gamaleya Institute and the RDIF have said that Sputnik V is 97.6% effective against COVID-19 in a “real-world” assessment based on data from 3.8 million people.
(Reporting by Vladimir Soldatkin; Editing by Mark Heinrich)
